Navigation Links
OHK Medical Devices to Exhibit at 2013 American Academy of Orthopedic Surgeons (AAOS) in Chicago
Date:2/28/2013

Chicago, IL (PRWEB) February 28, 2013

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will be exhibiting at the 2013 American Academy of Orthopedic Surgeons (AAOS). The meeting will take place March 20th through the 22nd in Chicago. The company is excited to celebrate major clinical milestones and increase the presence of the growing tourniquet of choice.

In 2012 OHK Medical Devices celebrated the 500,000 application of HemaClear®. Further, it celebrated the successful launch of HemaClear® in multiple countries including Australia, France and South Korea.

“We are very excited to showcase our tourniquet technology at the AAOS. The conference provides a unique opportunity to introduce surgeons to the first innovation in the field in over a century" said Omer Inbar, VP of Sales, OHK Medical Devices. Mr. Inbar added that “After a very strong year in 2012, we are off to a fantastic start in 2013 as HemaClear sales continue to take off. Our current expansion efforts combine creating a presence in new markets such as Latin America, Eastern Europe and Scandinavia and deepening our footprint in the existing markets in Europe and the US.”

OHK Medical Devices will be exhibiting in the main hall of the McCormick Center booth #1108. Surgeons and industry professionals are urged to come by the booth and learn why HemaClear® is quickly becoming the global tourniquet of choice.

About HemaClear®
HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in almost 500,000 procedures. Easier, cheaper and safer than the standard offerings, HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10472923.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
2. IpAuctions™, Inc. "All Things Medical" Auction event is opening March, 2013.
3. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
4. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
5. Quantason Names Dr. Ellen B. Mendelson, Medical Director
6. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
7. Vista College Introduces Its New Medical Laboratory Technician Diploma Program At El Paso Campus
8. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
9. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
10. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
11. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, ... begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. ... healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed on ...
(Date:2/23/2017)... NC (PRWEB) , ... February 23, 2017 , ... ... to announce a new partnership with Compass Research . GGI's mission is to ... a vaccine to a child in need in honor of each clinical trial volunteer. ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one members of ... Fellows of the Society this year, the Fellows Committee has announced. The honor ... optics, photonics, and imaging as well as their service to the Society and ...
Breaking Biology Technology:
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
Breaking Biology News(10 mins):